ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Demis Hassabis' Isomorphic Labs raised a massive $5bn Series C funding round co-led by Greenoaks and Sequoia. The company, spun out of Google DeepMind, uses AI to power drug discovery for cancer and immune disorders. Funds support clinical trials and expanding its proprietary IsoDDE engine.
Tap to vote and see what everyone thinks.
Summary by ByteBrief